Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Genomica Corp. (NasdaqNM:GNOM)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Recent Events
Aug 29Price hit new 52-week low ($2.96)
Aug  7Earnings Announcement
Location
1745 38th Street
Boulder, CO 80301
Phone: (720) 565-4500
Fax: (720) 402-9877
Email: investor_relations@genomica.com
Employees (last reported count): 127
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Technology
 ·Industry: Software & Programming
Company Websites
 ·Home Page
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 57%
·Institutional: 47% (108% of float)
(47 institutions)
·Net Inst. Buying: 4.45M shares (+29.43%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Genomica Corp. is a provider of software products and services that are designed to enable pharmaceutical and biotechnology researchers to accelerate the drug discovery and development process. Discovery Manager, the Company's first product, is used for genomics research, including genetic research, gene discovery and pharmacogenomics. This product allows researchers to turn the vast volumes of gene, SNP, protein and patient data from diverse sources into information useful for drug discovery. The Company licenses Discovery Manager to genomics-based research organizations, including AstraZeneca, GlaxoSmithKline, Pfizer, National Institutes of Health, University of Oxford and the National Cancer Institute.
More from Market Guide: Expanded Business Description

Financial Summary
Genomica Corp. is a provider of software products and services that are designed to enable pharmaceutical and biotechnology researchers to accelerate the drug discovery and development process. For the six months ended 6/30/01, total revenue rose 18% to $907 thousand. Net loss applicable to Common decreased 61% to $11.1 million. Results reflect licensing fess from the LinkMapper product, consulting fees from Applied Biosystems and the absence of preferred dividends.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

James Rathmann, 49
Chairman
--  --  
Teresa Ayers, 48
CEO, Director
$292K$5.8M
Thomas Marr, Ph.D., 49
Pres, Chief Scientist
270K2.4M
Daniel Hudspeth, 38
CFO, VP-Fin., Treasurer, Sec.
175K2.6M
Kenneth Rubin, 36
Exec. VP of Commercial Devel.
243K409K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:GNOMAs of 31-Aug-2001
Price and Volume
52-Week Low
on 29-Aug-2001
$2.96 
Recent Price$3.13 
52-Week High
on 29-Sep-2000
$23.375
Daily Volume (3-month avg)123.8K
Daily Volume (10-day avg)50.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y]
26-Week Change-43.1%
26-Week Change
relative to S&P500
-38.0%
Share-Related Items
Market Capitalization$71.8M
Shares Outstanding23.0M
Float9.90M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$5.28 
Earnings (ttm)-$6.40 
Earnings (mrq)-$0.26 
Sales (ttm)$0.10 
Cash (mrq)$2.52 
Valuation Ratios
Price/Book (mrq)0.59 
Price/EarningsN/A 
Price/Sales (ttm)29.72 
Income Statements
Sales (ttm)$1.78M
EBITDA (ttm)-$16.2M
Income available to common (ttm)-$24.2M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-26.51%
Return on Equity (ttm)-36.64%
Financial Strength
Current Ratio (mrq)27.53 
Debt/Equity (mrq)0 
Total Cash (mrq)$57.5M
Short Interest
As of 8-Aug-2001
Shares Short4,000 
Percent of Float0.0%
Shares Short
(Prior Month)
5,000 
Short Ratio0.02 
Daily Volume182.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Some event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.